article thumbnail

Expanding Innovation and Education in Medical Aesthetics

Dermatology Times

Bob Rhatigan, CEO of Merz Aesthetics, discusses the company’s commitment to advancing the aesthetics industry through strategic partnerships, specialized training, and a growing portfolio of injectables and devices.

article thumbnail

Arch Amenities’ Catherine Warren on technology & creating memorable experiences.

Spa Executive

Catherine Warren is Vice President of Strategic Partnerships at Arch Amenities Group, a provider of comprehensive amenity management and consulting services for hotels, residential complexes, and commercial real estate. Moreover, I’m excited about the prospect of scaling our impact through education and training initiatives.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Auberge’s new Global VP of Wellbeing, Vivianne Garcia-Tunon, talks wellbeing, wellness travel & more

Spa Executive

As global vice president of wellbeing, she will develop and deepen the wellness experience across Auberge Resorts Collection’s portfolio. I am particularly thrilled about reshaping the very concept of design-driven well-being within our global portfolio. What are you most excited about?

article thumbnail

Partner spotlight: Outpace the competition with Infor + Book4Time

Spa Executive

T he partnership between Infor Hospitality Management Solution and Book4Time is a step forward in improving guest experience and operational efficiency. This means a guest staying at one hotel can visit a spa at another hotel in your company portfolio and charge the experience back to the room at the hotel where they are staying.

article thumbnail

FDA Nod for Ustekinumab Biosimilar

The Dermatology Digest

market, is an important milestone on our pathway to consistently broadening our biopharma portfolio in the U.S. In February 2023, Fresenius Kabi and Formycon entered into a global commercialization partnership for the ustekinumab biosimilar candidate covering key global markets. and worldwide.

article thumbnail

How to Open a New Aesthetic Medicine Practice

AAAMS

That’s why when you train with the AAAMS, you’ll get access to our professional Aesthetics Network , a centralized hub for supporting you every step of the way.

article thumbnail

Done Deal: Organon Completes Acquisition of Dermavant

The Dermatology Digest

The future of dermatology depends on innovative treatments like VTAMA, and Organon’s acquisition of Dermavant allows us to further expand our existing portfolio of established brands and biosimilar dermatology treatments,” says Kevin Ali, Chief Executive Officer of Organon, in a news release.